Dr. Michelle Oblak is a veterinary surgical oncologist and Associate Professor of Soft Tissue and Oncologic Surgery in the Department of Clinical Studies, Ontario Veterinary College. Her research program focuses on translation, innovation and the incorporation of novel techniques and technology in treatment of patients, most often in a clinical trials setting. She has several collaborations considering dogs as a naturally occurring disease model for cancer in humans.
She is the Animal Health Partners Research Chair in Veterinary Medical Innovation (https://veterinaryinnovation.uoguelph.ca/), a co-director of the University of Guelph Institute for Comparative Cancer Investigation (ICCI, https://icci.uoguelph.ca/), and an active member of the Dog Osteosarcoma Group: Biomarkers of Neoplasia (DOG BONe) and Rapid prototyping of patient-specific implants for dogs (RaPPID) working group. Michelle also serves as the Chair of the Veterinary Society of Surgical Oncology (VSSO) Research Committee, an international organization that works to advance the understanding and improve treatment of veterinary patients with cancer